Twenty-five percent of the population in the United States is under the age of 14. What’s more, one-quarter of these children have some type of visual need.
Data demonstrates efficacy of FDA-approved therapy for treating amblyopia in children
Commercial real estate and your practice, part two with Colin Carr
Vyluma meets with FDA to discuss atropine sulfate ophthalmic solution 0.01% for the treatment of pediatric myopia
Tips, tricks, what to dos and what not to dos on how you can save money as a healthcare provider on your commercial real estate (Part 1)
Dopavision reports positive results from MyopiaX-1 trial on pediatric myopia management
Mental health and ophthalmology